United-Guardian, Inc.

NasdaqGM UG

United-Guardian, Inc. Market Capitalization on January 14, 2025: USD 48.22 M

United-Guardian, Inc. Market Capitalization is USD 48.22 M on January 14, 2025, a 34.04% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • United-Guardian, Inc. 52-week high Market Capitalization is USD 72.96 M on September 30, 2024, which is 51.31% above the current Market Capitalization.
  • United-Guardian, Inc. 52-week low Market Capitalization is USD 33.54 M on January 29, 2024, which is -30.44% below the current Market Capitalization.
  • United-Guardian, Inc. average Market Capitalization for the last 52 weeks is USD 47.09 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NasdaqGM: UG

United-Guardian, Inc.

CEO Ms. Donna Vigilante
IPO Date March 17, 1980
Location United States
Headquarters 230 Marcus Boulevard
Employees 23
Sector Consumer Discretionary
Industries
Description

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.

Similar companies

UTMD

Utah Medical Products, Inc.

USD 61.49

0.77%

UNB

Union Bankshares, Inc.

USD 29.12

-0.27%

UNTY

Unity Bancorp, Inc.

USD 43.31

1.69%

StockViz Staff

January 15, 2025

Any question? Send us an email